GeoVax Labs, Inc. (GOVX) stock
GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.01−0.01 (-0.50%)
Close on Nov 17, 2026Market cap $14.81MP/E –Yield –
GeoVax Labs total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
GeoVax Labs's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $0 | -100.0% |
| FY2020 | Dec 31, 2020 | $14.74K | -45.9% |
| FY2019 | Dec 31, 2019 | $27.24K | -31.2% |
| FY2018 | Dec 31, 2018 | $39.58K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $0 | -100.0% |
| Q2 FY2021 | Jun 30, 2021 | $0 | -100.0% |
| Q1 FY2021 | Mar 31, 2021 | $12.16K | -50.9% |
| Q4 FY2020 | Dec 31, 2020 | $14.74K | -45.9% |
| Q3 FY2020 | Sep 30, 2020 | $18.51K | -36.6% |
| Q2 FY2020 | Jun 30, 2020 | $21.70K | -32.8% |
| Q1 FY2020 | Mar 31, 2020 | $24.78K | -30.0% |
| Q4 FY2019 | Dec 31, 2019 | $27.24K | -31.2% |
| Q3 FY2019 | Sep 30, 2019 | $29.17K | -31.7% |
| Q2 FY2019 | Jun 30, 2019 | $32.29K | -29.5% |
| Q1 FY2019 | Mar 31, 2019 | $35.42K | -27.7% |
| Q4 FY2018 | Dec 31, 2018 | $39.58K | – |
| Q3 FY2018 | Sep 30, 2018 | $42.71K | – |
| Q2 FY2018 | Jun 30, 2018 | $45.83K | – |
| Q1 FY2018 | Mar 31, 2018 | $48.96K | – |
See a number that looks wrong?